Troy Baudino

Troy Baudino has extensive work experience in the field of medical science liaisons and medical affairs. Troy has held various senior positions in pharmaceutical companies such as Kura Oncology, Inc., Epizyme, Mesoblast Limited, AMAG Pharmaceuticals, and Mallinckrodt Pharmaceuticals. In these roles, they have been responsible for establishing and maintaining scientific relationships with key healthcare access decision makers, engaging with key opinion leaders (KOLs), supporting clinical trials and research initiatives, providing medical information to healthcare professionals, and mentoring new team members. Prior to their industry roles, Troy worked in academia as an associate professor and adjunct associate professor, focusing on cardiovascular disease, cancer research, and mentoring medical residents. Troy holds a postdoctoral fellowship from St. Jude Children's Research Hospital and has conducted research on oncology, hematology, and angiogenesis.

Troy Baudino earned a Bachelor of Science degree in Biology from Bradley University, where they attended from 1989 to 1993. Troy then pursued a Ph.D. in Cell and Molecular Biology at Saint Louis University School of Medicine, completing their doctoral studies from 1995 to 1999.